A federal securities class action has been filed against SES AI Corporation (NYSE: SES), alleging the company misled investors about its financial performance and business prospects. Shareholders who purchased SES shares between January 29, 2025 and March 4, 2026 have until June 26, 2026 to apply to the court to be appointed as lead plaintiff.
The Allegations
The complaint, filed by Wolf Haldenstein Adler Freeman & Herz LLP, alleges that SES AI made false or misleading statements and failed to disclose several key issues during the Class Period. Specifically, the suit claims that SES AI overstated its business prospects by materially overstating the expected results achievable through deals with companies that have limited or no operations. It also alleges that SES AI created an appearance of revenue by purchasing services in exchange for purchases of Molecular Universe. Additionally, the complaint states that contrary to positive statements about growth prospects, SES AI was affected by material logistics constraints in the fourth quarter of 2025, which would materially affect Q4 2025 revenues. These issues, the suit argues, called into question SES AI's growth prospects for 2026, which were later confirmed due to lower-than-expected 2026 revenue guidance.
The Trigger Event
On March 4, 2026, SES AI reported its fourth quarter and full year 2025 financial results. The company disclosed that logistics constraints delayed shipments at the end of the year, pushing approximately $1.5 million of expected revenue into the first quarter of 2026. This disclosure followed SES's presentation at the 28th Annual Needham Growth Conference on January 16, 2026, where the company discussed its business outlook and growth initiatives but did not disclose that shipment delays were affecting revenue timing. Following the March 4 announcement, SES's stock price fell $0.63 per share, or 36.84%, closing at $1.08 per share on March 5, 2026.
What Shareholders Should Know
Investors who purchased SES AI shares during the Class Period and suffered losses are eligible to participate in the lawsuit. The lead plaintiff deadline is June 26, 2026. Those interested in serving as lead plaintiff or seeking more information can contact Wolf Haldenstein Adler Freeman & Herz LLP at (800) 575-0735 or (212) 545-4774, or via email at [email protected]. There is no cost or obligation to speak with an attorney.
Bottom Line
SES AI shareholders who bought stock between January 29, 2025 and March 4, 2026 have a limited window to act. The June 26, 2026 lead plaintiff deadline is approaching, and affected investors should consider contacting the law firm to discuss their options.